Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome; and FHD-609, a small molecule protein degrader for BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and with Loxo Oncology to create novel oncology medicines. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Foghorn Therapeutics Inc..
Foghorn Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Foghorn Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Foghorn Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Foghorn Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Foghorn Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Foghorn Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Foghorn Therapeutics Inc.- Key Facts
2.2 Foghorn Therapeutics Inc.- Geographic Locations
2.3 Foghorn Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Foghorn Therapeutics Inc.- Business Divisions
2.5 Foghorn Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Foghorn Therapeutics Inc. Strategic Analysis Review
3.1 Foghorn Therapeutics Inc.- Key Strategies
3.2 Foghorn Therapeutics Inc.- Company Outlook Statement
3.3 Foghorn Therapeutics Inc.- SWOT Analysis
3.3.1 Foghorn Therapeutics Inc.- Key Strengths
3.3.2 Foghorn Therapeutics Inc.- Key Weaknesses
3.3.3 Foghorn Therapeutics Inc.- Potential Opportunities
3.3.4 Foghorn Therapeutics Inc.- Potential Threats
3.4 Foghorn Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Foghorn Therapeutics Inc.- Business Overview
4.2 Foghorn Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Foghorn Therapeutics Inc.- Key Products
5.2 Foghorn Therapeutics Inc.- Key Service Areas
5.3 Foghorn Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Foghorn Therapeutics Inc.- Company History
6.2 Foghorn Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Foghorn Therapeutics Inc.- Income Statements
7.2 Foghorn Therapeutics Inc.- Balance Sheet
7.3 Foghorn Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Foghorn Therapeutics Inc.- Direct Competitors
8.2 Foghorn Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Foghorn Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Foghorn Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
